The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo
about
Neutrophil responses to injury or inflammation impair peripheral gustatory functionInhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice.The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and survival of human endometrial implants in the nude mice endometriosis model.Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subsetRoles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokinesThe broad-spectrum chemokine inhibitor NR58-3.14.3 modulates macrophage-mediated inflammation in the diseased retina.Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.Peritoneal adhesions in human and veterinary medicine: from pathogenesis to therapy. A review.The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.Targeting the "cytokine storm" for therapeutic benefit.Necroinflammation in Kidney Disease.The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage.
P2860
Q33787918-F6B5C67C-5B5F-43BC-B9B5-0AA0545EC039Q34336857-0C0B2536-224A-4891-AA10-C6691D5C7AD9Q34727292-599CC1A5-729D-4E84-99DE-56323B66DEF1Q36060343-B3FFB5F1-7EE5-4DF4-81E1-76FFC902C284Q36476661-2848DD97-20AE-408F-9E7F-544119F6E54BQ36612019-43DC693F-9F37-44F3-9613-18B3F0398D75Q37475022-B970C10E-6203-499D-B246-A3DC67FE2509Q37686513-B1A20A5C-BDB8-442D-82F7-E5812921DF99Q37989141-EA58F093-0787-491C-82AC-C56C213BF6F0Q38071254-04D4F875-5FC2-47A5-9C10-D0D44C86E079Q38579499-55D35BDB-60C1-4ECD-8DC3-343AD824C9FCQ40111002-FF0BD671-54C5-4B68-912C-E9F815AF7CA1Q42959201-094469DC-87B7-4032-A514-1A3E02E51ACD
P2860
The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@ast
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@en
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@nl
type
label
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@ast
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@en
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@nl
prefLabel
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@ast
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@en
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@nl
P2093
P2860
P1433
P1476
The pan-chemokine inhibitor NR ...... by lipopolysaccharide in vivo
@en
P2093
D J Grainger
J Reckless
L M Tatalick
P2860
P304
P356
10.1046/J.1365-2567.2001.01228.X
P407
P577
2001-06-01T00:00:00Z